Galen

Sales & Marketing

Company Profile – POA Pharma

In a landscape shaped by regulatory complexity, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.

Digital

Life Sciences Industry Report 2025 pt4 cover

Life Sciences Industry Report – Digital Health

One of the most remarkable shifts in modern healthcare is how seamlessly digital platforms are becoming part of the drug development journey.

News

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

Digital health investors getting choosier as sector matures

Despite the well-documented retreat from record levels of funding for digital health ven

Podcasts

UK pharma leadership and COVID-19: the pharmaphorum podcast

The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure business continuity and maintain patient access to med

Company Profile – POA Pharma

Life Sciences Industry Report – Digital Health

Digital health investors getting choosier as sector matures

UK pharma leadership and COVID-19: the pharmaphorum podcast

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Galen

Editor's Picks